🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/01/2007 41,10 41,50 40,20 40,48 -0,44% 3,16% 2.690
18/01/2007 42,45 42,80 40,40 40,66 -3,42% 5,65% 6.110
17/01/2007 41,40 44,10 41,10 42,10 +2,93% 7,25% 9.360
16/01/2007 40,10 44,60 40,00 40,90 +1,56% 11,47% 21.650
12/01/2007 40,20 41,30 39,60 40,27 -0,22% 4,23% 13.180
11/01/2007 40,00 40,90 39,20 40,36 +0,95% 4,25% 7.780
10/01/2007 41,00 41,00 39,40 39,98 -2,49% 3,90% 11.300
09/01/2007 43,20 43,20 40,20 41,00 -5,09% 6,94% 16.270
08/01/2007 44,30 44,30 42,80 43,20 -1,82% 3,39% 9.860
05/01/2007 44,20 44,20 43,20 44,00 -0,45% 2,26% 7.790
04/01/2007 44,00 44,20 43,00 44,20 +0,45% 2,73% 4.280
03/01/2007 43,80 44,90 43,00 44,00 +0,46% 4,34% 4.570
29/12/2006 44,70 44,90 42,50 43,80 -2,01% 5,37% 6.330
28/12/2006 43,90 45,40 43,00 44,70 +1,59% 5,47% 9.450
27/12/2006 41,50 44,90 41,50 44,00 +6,02% 8,19% 10.120
26/12/2006 42,00 42,00 41,10 41,50 -1,19% 2,14% 4.500
22/12/2006 44,70 44,70 41,10 42,00 +1,69% 8,05% 14.260
21/12/2006 43,80 43,90 40,60 41,30 -5,49% 7,53% 14.150
20/12/2006 44,22 44,40 43,00 43,70 -1,13% 3,17% 6.590
19/12/2006 44,00 44,30 44,00 44,20 -0,58% 0,68% 3.440
18/12/2006 45,50 45,50 44,00 44,46 -1,20% 3,30% 3.900
15/12/2006 46,00 46,10 45,00 45,00 -3,02% 2,39% 9.890
14/12/2006 47,60 47,60 46,30 46,40 -0,64% 2,73% 6.280
13/12/2006 45,70 47,60 45,20 46,70 +3,41% 5,25% 8.340
12/12/2006 45,30 45,50 44,50 45,16 -0,66% 2,21% 7.440
11/12/2006 46,20 46,30 45,00 45,46 -1,17% 2,81% 6.250
08/12/2006 47,00 47,10 45,41 46,00 +2,50% 3,60% 4.230
07/12/2006 46,70 46,70 44,80 44,88 -3,90% 4,07% 9.530
06/12/2006 47,20 47,40 46,40 46,70 -0,85% 2,12% 1.560
05/12/2006 46,30 47,70 46,30 47,10 +1,51% 3,02% 1.820